SRTA
Strata Critical Medical, Inc.
NASDAQ · Industrials · Airlines, Airports & Air Services · US
$5.32
−0.93%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 256.0M | 197.1M | 248.7M | 225.2M | 146.1M |
| Cost of Revenue | 203.4M | 156.0M | 189.8M | 183.1M | 123.8M |
| Gross Profit | 52.6M | 41.1M | 58.9M | 42.1M | 22.3M |
| Operating Expenses | |||||
| R&D Expense | 453.0K | 3.1M | 3.2M | 4.6M | 5.5M |
| SG&A Expense | 58.4M | 60.9M | 89.7M | 105.6M | 70.3M |
| General & Admin Expense | 25.1M | — | 81.7M | 95.2M | 62.5M |
| Selling & Marketing Expense | 849.0K | — | 8.0M | 10.4M | 7.7M |
| Other Expenses | 14.2M | (448.0K) | — | — | — |
| Total Operating Expenses | 73.0M | 63.5M | 92.8M | 110.2M | 75.8M |
| Cost and Expenses | 276.4M | 219.5M | 282.6M | 293.3M | 199.6M |
| Operating Income (EBIT) | (20.4M) | (22.4M) | (33.9M) | (68.1M) | (53.5M) |
| Non-Operating | |||||
| Interest Income | 2.6M | 4.2M | 7.2M | 8.4M | 3.4M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 2.6M | 4.2M | 7.2M | 8.4M | 3.4M |
| Other Non-Op Income/Expense | (2.8M) | 2.3M | 6.4M | 10.6M | 25.5M |
| Non-Operating Income (excl Interest) | 5.2M | (9.7M) | (6.4M) | (10.6M) | (25.5M) |
| EBT (Pre-Tax Income) | (23.2M) | (20.1M) | (27.6M) | (57.5M) | (28.0M) |
| Income Tax Expense | — | — | (255.0K) | (1.5M) | (772.0K) |
| Bottom Line | |||||
| Net Income | 40.2M | 41.3M | (27.3M) | (56.1M) | (27.3M) |
| Earnings from Cont. Ops | (23.2M) | (20.1M) | (27.3M) | (56.1M) | (27.3M) |
| Earnings from Discont. Ops | 63.4M | 61.4M | — | — | — |
| Bottom Line Net Income | 40.2M | 41.3M | (27.3M) | (56.1M) | (27.3M) |
| Per Share | |||||
| Basic EPS | $0.50 | $0.50 | ($0.35) | ($0.76) | ($0.38) |
| Diluted EPS | $0.50 | $0.50 | ($0.35) | ($0.76) | ($0.38) |
| Revenue Per Share | $2.97 | $2.39 | $3.21 | $3.06 | $2.05 |
| Shares | |||||
| Basic Shares Outstanding | 86.2M | 82.5M | 77.5M | 73.5M | 71.2M |
| Diluted Shares Outstanding | 86.2M | 82.5M | 77.5M | 73.5M | 71.2M |
| Profitability Metrics | |||||
| EBITDA | (9.4M) | (5.7M) | (21.6M) | (50.4M) | (22.3M) |
| D&A | 16.3M | 6.9M | 6.0M | 7.1M | 5.7M |
| EBIT | (25.6M) | (12.6M) | (27.6M) | (57.5M) | (28.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026